CSIMarket
 


Siga Technologies Inc  (SIGAQ)
Other Ticker:  
 
 

SIGAQ's Operating Income Growth by Quarter and Year

Siga Technologies Inc's Operating Income results by quarter and year




SIGAQ Operating Income (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December -3.47 -3.71 -3.63 0.00
III Quarter September 0.66 -4.53 -4.33 0.00
II Quarter June -1.71 -9.28 -5.04 0.00
I Quarter March 368.89 -7.06 0.00 0.00
FY   364.37 -24.58 -13.00 0.00



SIGAQ Operating Income fourth quarter 2018 Y/Y Growth Comment
Siga Technologies Inc in the fourth quarter 2018 recorded Operating Loss of $ -3.47 millions.

According to the results reported in the fourth quarter 2018, Siga Technologies Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Siga Technologies Inc' s Operating Income no change of % ranks overall at the positon no. in the fourth quarter 2018.

Explain Operating Income growth


SIGAQ Operating Income ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Siga Technologies Inc's fourth quarter 2018 Operating Income $ -3.47 millions SIGAQ's Income Statement
Siga Technologies Inc's fourth quarter 2017 Operating Income $ -3.71 millions Quarterly SIGAQ's Income Statement
New: More SIGAQ's historic Operating Income Growth >>


SIGAQ Operating Income (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income fourth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income fourth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Siga Technologies Inc's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SIGAQ's IV. Quarter Q/Q Operating Income Comment
Current results of -3.47 millions by Siga Technologies Inc appear even worse if you take a look at 0.66 millions Operating Loss in the previous quarter.

Within Major Pharmaceutical Preparations industry Siga Technologies Inc achieved highest sequential Operating Income growth. While Siga Technologies Inc's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SIGAQ's IV. Quarter Q/Q Operating Income Comment
Recent results of -3.47 millions by Siga Technologies Inc come out even less good if you take a look at 0.66 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Siga Technologies Inc achieved highest sequential Operating Income growth. While Siga Technologies Inc's Operating Income growth quarter on quarter, overall rank is .


Siga Technologies Inc's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
Cumulative Operating Income 12 Months Ending $ 364.37 $ 364.13 $ 358.94 $ 351.36 $ -24.59
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) 0.07 % 1.45 % 2.16 % - -
Seq. Operating Income Growth (TTM) Overall Ranking # 1341 # 906 # 738 # 0 # 0




Cumulative Operating Income growth Comment
In the Dec 31 2019 period, Siga Technologies Inc had cumulative twelve months Operating Income of $ 364 millions compare to Operating Loss of $ -25 millions a year ago.
Even more so, not just that Siga Technologies Inc has regained the prosperity, it by this time is improving fast with better then usual Operating Income rise, from the period from Sep 30 2019 to Jun 30 2018 of 0.07 % from $364.13 millions.

Siga Technologies Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 24
Sector # 81
S&P 500 # 1341
Cumulative Operating Income growth Comment
In the Dec 31 2019 period, Siga Technologies Inc had cumulative twelve months Operating Income of $ 364 millions compare to Operating Loss of $ -25 millions a year ago.
Besides Siga Technologies Inc has restored the bottom-line, Siga Technologies Inc is, as of now improving fast and recording higher than normal Operating Income gain, from the period from Sep 30 2019 to Jun 30 2018 of 0.07 % from $364.13 millions.

Siga Technologies Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 24
Sector # 81
S&P 500 # 1341




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
SIGAQ's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for SIGAQ's Competitors
Operating Income Growth for Siga Technologies Inc's Suppliers
Operating Income Growth for SIGAQ's Customers

You may also want to know
SIGAQ's Annual Growth Rates SIGAQ's Profitability Ratios SIGAQ's Asset Turnover Ratio SIGAQ's Dividend Growth
SIGAQ's Roe SIGAQ's Valuation Ratios SIGAQ's Financial Strength Ratios SIGAQ's Dividend Payout Ratio
SIGAQ's Roa SIGAQ's Inventory Turnover Ratio SIGAQ's Growth Rates SIGAQ's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2019
Prestige Consumer Healthcare Inc -1.47%$ -1.466 millions
Taro Pharmaceutical Industries Ltd-2.25%$ -2.250 millions
Cyclacel Pharmaceuticals Inc -2.73%$ -2.725 millions
Atrion Corporation-2.91%$ -2.909 millions
National Healthcare Corp-4.05%$ -4.054 millions
Koninklijke Philips Nv-4.36%$ -4.363 millions
Gilead Sciences Inc -4.46%$ -4.458 millions
Innoviva Inc -4.64%$ -4.637 millions
Vascular Biogenics Ltd -4.89%$ -4.893 millions
Msa Safety Incorporated-5.36%$ -5.364 millions
Merck and Co Inc -5.42%$ -5.416 millions
Lhc Group Inc -6.24%$ -6.242 millions
Pacific Health Care Organization Inc -7.48%$ -7.484 millions
Purple Biotech Ltd -8.56%$ -8.561 millions
Hologic Inc-11.17%$ -11.174 millions
Regeneron Pharmaceuticals Inc -13.41%$ -13.407 millions
Amgen Inc -14.02%$ -14.022 millions
Harvard Bioscience Inc-15.04%$ -15.040 millions
Fresenius Medical Care Ag-16.32%$ -16.324 millions
Antares Pharma Inc -17.99%$ -17.988 millions
Iqvia Holdings Inc -19.81%$ -19.807 millions
Phibro Animal Health Corporation-23.72%$ -23.718 millions
3m Company-25.69%$ -25.687 millions
Lantheus Holdings Inc -26.59%$ -26.589 millions
Alpha Pro Tech Ltd -28.07%$ -28.070 millions
Lemaitre Vascular Inc -31.49%$ -31.489 millions
Sanofi-33.17%$ -33.169 millions
Pfizer Inc-33.61%$ -33.607 millions
Boston Scientific Corporation-34.17%$ -34.169 millions
Conmed Corporation-35.31%$ -35.315 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com